Enanta Pharmaceuticals Announces National Institute of Allergy and Infectious Diseases (NIAID) Will Fund Further Development of a Novel Bicyclolide $9.2 million in Additional Funding Awarded to Enanta http://finance.yahoo.com/news/enanta-pharmaceuticals-announces-national-institute-120000624.html